190
Views
8
CrossRef citations to date
0
Altmetric
Review

Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (7)

T. Azad, H. J. Janse van Rensburg, E. D. Lightbody, B. Neveu, A. Champagne, A. Ghaffari, V. R. Kay, Y. Hao, H. Shen, B. Yeung, B. A. Croy, K. L. Guan, F. Pouliot, J. Zhang, C. J. B. Nicol & X. Yang. (2018) A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nature Communications 9:1.
Crossref
Rahil Eftekhari, Rezvan Esmaeili, Reza Mirzaei, Katayoon Bidad, Stacy de Lima, Maryam Ajami, Hedayatollah Shirzad, Jamshid Hadjati & Keivan Majidzadeh-A. (2017) Study of the tumor microenvironment during breast cancer progression. Cancer Cell International 17:1.
Crossref
Grace Gar-Lee Yue, Sida Xie, Julia Kin-Ming Lee, Hin-Fai Kwok, Si Gao, Yin Nian, Xiao-Xiao Wu, Chun-Kwok Wong, Ming-Hua Qiu & Clara Bik-San Lau. (2016) New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Scientific Reports 6:1.
Crossref
Mei Liu, Zhiyang Li, Jingjing Yang, Yanyun Jiang, Zhongsi Chen, Zeeshan Ali, Nongyue He & Zhifei Wang. (2016) Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment. Cell Proliferation 49:4, pages 409-420.
Crossref
Qunyi Li, Yi Wang, Liudi Zhang, Lu Chen, Yongli Du, Ting Ye & Xiaojin Shi. (2016) Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERR?/VEGF/KDR signaling pathway. Fitoterapia 111, pages 78-86.
Crossref
Omar Abdel-Rahman & Hesham ElHalawani. (2015) Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis. Future Oncology 11:21, pages 2949-2961.
Crossref
Omar Abdel-Rahman & Hesham ElHalawani. (2014) Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-Analysis. Chemotherapy 60:5-6, pages 325-333.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.